UK-based Ab­b­Vie sales rep rais­es con­cerns about 's­trate­gic loi­ter­ing' out­side hos­pi­tals dur­ing the pan­dem­ic

The UK’s Pre­scrip­tion Med­i­cines Code of Prac­tice Au­thor­i­ty (PM­C­PA) re­cent­ly dug in­to Ab­b­Vie’s sales prac­tices af­ter a UK-based rep com­plained that sales teams were al­leged­ly in­cen­tivized to have five face-to-face calls with health pro­fes­sion­als per week at a time dur­ing the pan­dem­ic when hos­pi­tals were not see­ing many pa­tients face to face.

While Ab­b­Vie main­tained that the rep’s rea­son for vis­it­ing the hos­pi­tal was to nab an ap­point­ment with a health pro­fes­sion­al, the PM­C­PA pan­el raised con­cerns about the rep­re­sen­ta­tive’s ref­er­ence to “strate­gic loi­ter­ing” out­side the hos­pi­tal.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER